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Summary Infectious diseases are the confrontation of two worlds, the microbial
world and the world of human physiology. Although these two worlds are as a whole
governed by the same laws of nature, they show substantial differences: the mi-
crobiological world is 1000 times older, and was initiated by the development of
the archaea, the ‘living organisms of the extreme’: its biomass and its diversity are
immense — two to three billion species or 60% of the total biomass of the planet.
The number of pathogens that adapted to man, however, is extremely limited —
barely 1000. Thus, over billions of years, an evolution of the microbial world took
place from ‘early life’, characterized by chemosynthesis, to the ‘modern pathogens’,
and entailed a dramatic ‘concentration’ of life conditions and an adaptation to-
wards a narrow range of requirements — those allowing survival in the human
body.
Within the last two centuries, these two slowly evolving systems, microbial life
and human life, were profoundly modiﬁed in an unprecedented manner by a third
player, human civilization, with its global impact on the environment through physical,
chemical, societal, and climatic determinants. An appreciation of the evolution of
infectious diseases in the 21st century and of the development of new diagnostic and
therapeutic strategies therefore requires a full understanding of these three domains:
human physiology, microbiology, and the environment.
This review will put major emphasis on the environmental role of civilization on
infectious diseases before considering new opportunities to combat them through
novel and creative solutions.
© 2003 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
*Tel.: +41-22-372-92-02; fax: +41-22-372-92-30.
E-mail address: francis.waldvogel@hcuge.ch
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Impact of human civilization on the
environment
The Greenhouse Effect
The distribution of gases in the earth’s atmosphere
— highly reactive O2, H2, CH4, among others — is
far from the balance predicted by physical laws
alone.1 As suggested by James E. Lovelock, life
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profoundly affects the earth’s atmosphere, re-
sulting in a close relationship between the atmo-
spheric, geological and biological environments.
These physical and biological considerations have
their poetical counterpart in the development
of the Gaia hypothesis (Goddess of Earth): the
earth is alive, the atmosphere is its circula-
tory system, life optimizes its own environment
in a cognisant way and through self-regulatory
feedback mechanisms. What scientiﬁc evidence
do we have that this interrelationship holds
true?
Climate change, as currently observed through
the global warming phenomenon, is exerting a pro-
found inﬂuence on life, and therefore on infectious
diseases, by changing their geographic distribution,
demographic data, as well as vector conditions.2
Climate, in turn is itself deeply inﬂuenced by the
evolution of the greenhouse gases of the last 200
years.
Since 1800, the CO2 concentration of the atmo-
sphere has risen by 30%, whereas the nitrous oxides
have increased by 20%, and methane concentration
has risen by more than 100%. These changes affect
profoundly the reﬂection and dissipation of solar
energy on the earth’s surface. All these effects,
summarized under the general term of the green-
house effect, have been intensiﬁed by additional
water evaporation. Global warming is estimated
at 1 ◦C per century. Although such gradual warm-
ing could be considered to be inconsequential, it
is to be noted that the last glacial period with its
dramatic consequences was due to a mere 5 ◦C
temperature change.
Global warming has already had a marked effect
on the planetary water and air cycles, as shown by
a few examples:3
• The sea level has already risen by 35 cm since
1900, changing many demographic conditions
and the epidemiology of many infectious diseases
such as malaria, dengue and cholera
• As another example, the El Nino — the southern
oscillation phenomenon which moves warm wa-
ters and rain to the Paciﬁc coast of South Amer-
ica in a one-in-every-four year cycle has shown
some ampliﬁcation. Thus, the most rapid spread
of the 1991 cholera epidemic in Peru along the
Paciﬁc coast, was associated with such a coastal
warming. The 1994 Bangladesh cholera epidemic
also closely followed the sea surface temperature
ﬂuctuations
• Other examples and threats include the Rift Val-
ley fever epidemic in East Africa 1997—98, and
the present dramatic geographic extension of
dengue and malaria.
Urbanization, the development of
megalopolis
In the last 50 years, the world’s landscape has been
profoundly modiﬁed by a vast and relentless soci-
etal movement from the countryside to the cities,
as shown by the following numbers. It is considered
today that 47% of the world’s population is urban-
ized. By 2030, it will be 60% or 4.9 billion people.
By as early as 2007, urban dwellers will exceed the
rural population for the ﬁrst time in history. This
historical trend towards urbanization is particularly
marked in the developing world. If in the indus-
trialized countries, the number of megalopolis has
been kept at 6 over 50 years, the number will in-
crease from 5 to 27 in countries in development,
creating totally new environmental conditions. This
rapid urban growth puts a strain on the capacity of
local and national governments to come up with ad-
equate provision of water, electricity, sewage and
social services. Historical scourges such as tubercu-
losis, hepatitis and sexually transmitted infections,
and new diseases such as AIDS ﬁnd ideal breeding
conditions in this new, radically altered environ-
ment. An example of this dramatic situation is re-
lated to the problem of access to water: water is not
only elementary to human life, it is also the ideal
milieu for pathogen development and transmission.
Access to drinking water and sanitation systems are
still unsolved problems of humanity. It is estimated
that by 2010, one third of humanity will not have
access to this elementary life system and/or to ad-
equate sewage systems. The ﬁght for clean water
could well become amajor driving force of our glob-
alized political system in the near future.4
World migration
Our transformed planetary ecosystem is perma-
nently traversed by millions of people travelling.
The World Migration Report 2000 from the Inter-
national Organization for Migration gives some im-
pressive numbers, regarding population movements
across borders;5 it does not take into consideration
hidden problems of internal displacements and of
illegal migrants; they are often victims of profes-
sional networks specialized in human trafﬁcking,
and are exposed to dramatic health conditions.
A few numbers will illustrate this new epidemi-
ology: the number of displaced people around
the world reached 150 million by 2000, and this
number does not take into account internally dis-
placed populations — such as frequent during civil
wars — nor does it take into account illegal mi-
gration, which accounts for many more millions —
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close to 15. Although voluntary migrants are often
spurred by economic motives, most refugees es-
cape under precarious conditions such as human
violence or natural catastrophes. They are usually
poor, live under dismal conditions, and encompass
70—90% women and children. In addition to the
demographic, political, cultural and societal conse-
quences of this global ethnic displacement, serious
problems arise regarding infectious diseases.6 In
the short term their spreading typically involves in-
fections associated with poor hygiene, poor access
to safe water, promiscuity or overpopulated liv-
ing quarters. Diarrheal diseases, upper respiratory
disease, hepatitis and sexually transmitted infec-
tions, are the main infectious consequences of this
acute situation. The incubation periods of many of
these infectious diseases are longer than modern
travel times, rendering old fashioned quarantine
measures obsolete. In a longer timescale, more
hidden, chronic diseases also have to be considered
because they create new public health conditions,
which require a reorganization of the health care
system in order to control them. Examples include
multidrug resistant tuberculosis, hepatitis B, hep-
atitis C and hepatoma, papilloma virus and cervical
cancer, HIV and other lentivirus.
The food market
The food market has also followed the globalization
process, and — as demonstrated by bovine spongi-
form encephalopathy and its health and political
consequences — has become impossible to control.
This is also true for less dramatic food-borne dis-
eases: thus, it is estimated that in the US, 76 mil-
lion cases of food-borne disease occur each year,
of which the known conventional and well known
pathogens represent only 14 million (20%) — about
20 bacterial species, ﬁve parasites and four groups
of viral agents.7 This network of mass cultivation
of food products, of conditioning, mixing, import-
ing and exporting food products, not to speak about
massive meal preparations for schools, cafeterias
etc, has become so entangled and complex that its
control by usual public health measures is beyond
our capability.
Bioterrorism
Six billion humans have progressively conquered
our planet and have thereby created new living
conditions that are conducive to the widespread
development of old and new infectious diseases;
this historical movement, known since the Renais-
sance and recently ampliﬁed, has abolished ecolog-
ical niches of pathogens and put them into contact
with new, susceptible populations. This process is
still under way and further ‘encounters’ of locally
adapted, or even hidden, new pathogens by sus-
ceptible individuals can be foreseen. This risk will
be difﬁcult to manage in a world of little concern
for potential dangers. This undesired globalized
risk due to lack of foresight is presently further
aggravated by another potentially devastating phe-
nomenon, i.e. voluntary contamination or bioter-
rorism. Many leading personalities in the world of
microbiology, among them the Nobel Prize winner
Joshua Lederberg, have warned for many years
that microorganisms could be used as ‘the poor
nation’s atomic bomb’. Today the list encompasses
ﬁve major pathogens. Anthrax,8,9 botulism,10 tu-
laremia, plague, smallpox,11 and genetically mod-
iﬁed infectious agents. All these organisms have
received adequate coverage by the medical and
lay press, and will therefore not be discussed. A
few general comments are nevertheless in order:
the recent bioterrorism threats have revealed that
bioterrorist strategies have been developed in hid-
ing for many years and 17 countries have acknowl-
edged that they have had an offensive biowarfare
program.
Several attempts to use bioterrorist weapons ac-
tively have fortunately failed on a large scale. This
is certainly not reassuring. Although the manufac-
turing of lethal bioweapons requires access to ad-
vanced technology, even their limited use in a well
concerted strategy can have psychological, societal
and political impacts almost as important in their
paralyzing effect as the eradication of a whole pop-
ulation segment, as demonstrated by the recent an-
thrax threat in the US and in other countries. More-
over, local decontamination will entail solving al-
most insurmountable problems, as shown by a UK
report after World War II: 36 years later, in a small
island off the Scottish coast which was used for an-
thrax exposure testing, the ground still contained
anthrax spores and required 280 tons of formalde-
hyde for decontamination.
Examples of emergent and re-emergent
infectious diseases
The list of new organisms or re-emergent organisms
is, by deﬁnition, incomplete, constantly changing
and operational.12,13 Table 1 is not intended to give
a complete overview, but rather to show the im-
mense diversity of the most important emergent
pathogens. Such a list would not be complete with-
out mentioning another type of emergent epidemic,
maybe the most important one, also caused by our
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Table 1 Examples of emerging and reemerging infectious diseases. (Incomplete) (modiﬁed from Gushulak6).
Infectious agent Clinical outcome
Prion agent and BSE Var. Creutzfeld Jakob disease
Viruses
Hantavirus Chronic renal failure
Hepatitis B Chronic hepatitis, hepatoma
Hepatitis C Chronic hepatitis, hepatoma
HIV AIDS
HTLV Lymphoma
Papilloma Cervical carcinoma
Dengue Extension of risk area
West Nile Fever Encephalitis with ↑ mortality: US, Israel, etc.
Bacteria
Helicobacter pylori Peptic ulcer, gastric carcinoma
Mycobacterium tuberculosis Reactivation tuberculosis
Multidrug resistance: Salmonella spp, Shigella spp,
Staphylococcus aureus, Streptococcus pneumoniae,
Enterococcus faecalis
Increased morbidity and mortality
Parasites
Trypanosoma cruzi Chronic Chagas disease
Plasmodium falciparum Extension of malaria
own mismanagement — the new epidemic of mul-
tidrug resistance.
The discovery and development of antimicro-
bials, only 60 years ago, has indeed added a
formidable pressure on the microbial population
in contact with the human species. However mi-
crobial adaptation has been not only multifaceted,
but also fast when compared to the previous evolu-
tion of life. So far, resistance to antimicrobials has
developed among any pathogen (bacteria, viruses,
parasites) exposed to any new antiinfective agents.
The mechanisms of bacterial resistance are es-
sentially of two genetic types:14,15 mutation, and
various genetic exchange systems such as trans-
duction and conjugation. If these biological mech-
anisms create the genetic blueprint for new re-
sistance patterns, it is their proliferation under
selective pressure which creates the conditions for
new epidemics (hospitals, agriculture, ambulatory
care facilities). A recent study, sponsored by the
European Community banning a vancomycin ana-
logue (aparmycin) from animal feed and resulting
in a decreased prevalence of vancomycin resistant
enterococci, is a case in point to show us where
future strategies should go, if we do not want to
ﬁnd ourselves at the end of the antibiotic era.16
New opportunities and strategies
In this globalized world, the human species is again
endangered by infectious diseases and will have
to use all its creative strength to ﬁnd new solu-
tions: this new world now requires new scientiﬁc
approaches. Scientiﬁc research has evolved in re-
cent times more towards understanding these phe-
nomena at the micro- and even at the nanolevel,
rather than in their global expression of complexity.
Without belittling the important discoveries made
in epidemiology and environmental research, we
must appreciate that it is mostly at the small scale
level that the impetus of science has its major im-
pact today. In the following, new developments at
the micro- and nanolevel of life sciences will be
described, which will hopefully help to solve some
of the major challenges to mankind previously de-
scribed. A few important developments — method-
ological, scientiﬁc, technical — will be described
which will in all probability deeply inﬂuence our un-
derstanding of infectious diseases.
Quorum sensing
It is generally accepted that within a colony or
an infectious process, all bacteria are identical
and represent a clone originating from an origi-
nal blueprint. Important new scientiﬁc informa-
tion gathered over the last few years has shown,
however, that a given bacterial population is het-
erogenous, and that the individual behaviour of
each cell is determined by factors linked with the
population density: soluble compounds are liber-
ated by each cell into its surroundings, affecting
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through a receptor-second-messenger mechanism,
the neighbouring cells;17 this is an ‘effect at a
distance’ akin to the pheromone action in insects.
The mechanisms underlying this phenomenon have
been elucidated in many species, including Staphy-
lococcus aureus: the pheromone here is an eight
aminoacid peptide, and the process is population
density dependent. At the end of an exponential
growth phase, this cell-to-cell interaction mecha-
nism causes down-regulation of cell surface com-
ponents (unnecessary for survival at this stage)
and upregulation of secretion factors and toxins.18
This expanding new universe of interbacterial com-
munication offers totally new avenues for useful
applications in biotechnology, ecology and human
diseases. Substances inhibiting cell-to-cell com-
munication could well avoid the establishment of
bacterial nidation and represent a new genera-
tion of antimicrobials which are less prone to the
emergence of resistance.
Genomics
The whole bacterial genome resides in a molecule
1 femtogram in weight. Whereas until recently, the
isolation or/and characterization of a single gene
was a PhD performance, new technologies have
driven this ﬁeld to allow rapid high throughput
screening of whole bacterial genomes. By 2001, 37
microbial genome sequences had been completed,
and 142 were in progress worldwide.19 The recent
development of robotics to achieve high spotting
densities of DNA on glass slides allows the construc-
tion of microarrays containing up to 50,000 genes
on a single microscopic slide. This sequencing tech-
nique helps to accumulate important data that
could usefully answer many important questions
regarding human pathogens: bacterial evolution,
identiﬁcation of potential virulence genes, analysis
of epidemics and rapid diagnostic methods in clin-
ical microbiology, are but a few among the most
important ones.
Microbial gene expression proﬁling
Microbial gene expression proﬁling has rapidly
taken the lead in this ﬁeld and is superseding sim-
ple genome sequencing: assessment of transcrip-
tion with cDNA microarrays provides a dynamic
picture of microbial or host tissue behaviour ‘in
real life’ i.e., during the infectious process.20 Gene
expression proﬁling allows observation of ‘life in
the city’ under the most diverse conditions.21 The
technical problems of unstable mRNA have been
largely solved, and enormous quantities of data at
various time points can be analyzed by bioinfor-
matics tools or expressed visually. Bacterial tar-
gets essential for survival can thus be identiﬁed,
allowing the screening of new compounds active
on highly conserved targets in various species —
a condition necessary for broad spectrum antimi-
crobials — or inversely hitting speciﬁc targets — a
condition necessary for selective therapy. Bioin-
formatics tools and high throughput screening are
indispensable technologies to master these new
strategies.
Such genome expression analysis will help in the
search for new antibiotics and will supersede the
usual, conventional and time-honoured approach
of whole cell antimicrobial screening; although this
methodology has been historically successful and
reproducible, it is rather insensitive, empirical,
and has led to the limited discovery of natural com-
pounds with narrow targets: the cell wall, protein
synthesis and DNA replication. The novel approach
based on genome expression, very sensitive and
efﬁcient, detects new potential action sites and
favours a rational drug design.22 Problems to be
solved will include penetration issues, identiﬁca-
tion of processes independent of gene expression
and — as always — the long itinerary of research
from the bench to the bedside.
Data handling and simulation systems
The data which accumulate in microbiology and in
life sciences no longer allow all new hypotheses and
experimental conditions to be put to the test. Vir-
tual experimentation has therefore become part of
laboratory exploration, as shown recently with the
publication of an artiﬁcial cell — the e-cell.23 This
model has 102 protein encoding genes and 22 RNA
encoding genes, and consists in 495 reaction rules.
When simulation starts, all reactions are started in
parallel and the genomic expressions are monitored
using a genemap window. This allows artiﬁcial test-
ing of various conditions, thereby allowing concen-
tration on crucial real experiments.
Combinatorial chemistry
Combinatorial chemistry has also evolved as an ef-
ﬁcient tool in the screening for new antiinfectives,
in association with other experimental procedures.
The strategies followed are the systematic search
for novel targets, the improvement of compounds
inhibiting resistance enzymes, or the modiﬁcation
of known, useful antibiotics. Vancomycin is an in-
teresting case in point. Derivatives of vancomycin
— an antibacterial which has increased activity
as a dimer — can be reconstructed with various
new building blocks in the presence of its usual
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Table 2 Nanosciences and nanotechnology.
Examples
Nanospheres (Fullerenes),
nanotubes, nanostructures
Nanocapsules (with receptors),
nanorobots, nanomotors
Nanosensors (intracellular)
Self replicating biowatch
Applications
Sensors: pressure, olfactory, chemical
Nanobots: clot lysis, arterial repair,
tumour destruction
Self assembly: toxicology, environment
substrates, and its potential increase in antibiotic
action, tested ﬁrst in computer models and there-
after in an in vitro system.
Nanotechnology and nanobiology
In recent years, remarkable progress has been
achieved at an ever lower level of the life scale
— at the level of the nanometer. Search for drug
discovery and delivery is moving smaller;23,24 drug
targeting against tumour vessels for instance has
become now a reality,25 and many new biologi-
cally active nanostructures are being developed:
‘Macrodoctors, come meet the nanodoctors’ is soon
to become a reality (Table 2).26
Vaccinology
Modern vaccinology has also made spectacular
progress in recent years by the use of the most
modern technologies. The list regarding the pro-
duction of active immunization systems is indeed
impressive.27 The eradication of many diseases
Table 3 The status of vaccines against human pathogens (modiﬁed from Ada27).
Bacteria Viruses Parasites
Bacillus anthracis Adenovirus Leishmania (phase 3)
Bordetella pertussis Hepatitis A Coccidioides (phase 2)
Borrelia burgdorferi Hepatitis B
Clostridium tetani Inﬂuenza A, B (phase 3)
Corynebacterium diphtheriae Japanese encephalitis
Coxiella burnetii Measles
Mycobacterium leprae (phase 2) Polio
Mycobacterium tuberculosis Rabies
Neisseria meningitidis Rubella
Salmonella typhi Vaccinia
Streptococcus pneumoniae Varicella-Zoster
Vibrio cholerae Yellow fever
around the world has now become a realistic goal.
Long term consequences of chronic diseases, such
as hepatitis B induced hepatoma, have been clearly
shown to be drastically reduced among children
in Taiwan.28 New vaccine strategies are being ex-
plored, such as the use of conjugated vaccines,
recombinant proteins, pseudovirions and DNA vac-
cines. Delivery systems are also improving with the
exploration and implementation of transdermal
applications, microencapsulation and plant expres-
sion of antigens. It is hoped that research in this
ﬁeld will soon help to control, at affordable prices,
diseases such as malaria, HIV, and M. tuberculosis.
A list of the immunization procedures available
today or in a near future is given in Table 3.
An attempt at integration — conclusions
If yesterday these two worlds, the microbial world
and human civilization, were limited in their con-
tact by environmental conditions determining
ecological niches, modern life has dramatically
changed this ordered relationship. We are the wit-
nesses and also the pilots and victims of a new,
disrupted system, where the old rules of limited
mutual interaction are no longer valid. Frontiers
are abolished; free circulation of man and products
is the rule; human immigration into cities leads to
new microbial concentrations; massive inﬂuence of
civilization on the environment reshufﬂes epidemi-
ologic conditions — infectious diseases in particular
and health in general have also become globalized
(Figure 1).
It is time, therefore, to consider new solutions
at the global level — at country, continent, and
planetary levels. Infectious diseases in modern
times can only be comprehended as a science with
a new approach acknowledging the environment as
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Figure 1 An attempt at integration: conclusions.
one of the important players in the ﬁeld; hospital
and public health, geographical, societal and po-
litical strategies have to be included in eradication
strategies. The modern infectious diseases special-
ist has therefore to be a socially conscious, respon-
sible person, more so than any other specialist in
medicine except, maybe, the psychiatrist. Areas of
general interest and importance, and in which rapid
progress should be made include the following:
• Sustainability, in order to prevent the irreversible
transgression of critical thresholds (ocean belt
conveyors, ice shield, ozone layer, rain forests)
which could alter dramatically our living condi-
tions
• Epidemiology, with an expansion into new ﬁelds
driving this science, such as economic, social, be-
havioural contexts
• Collective action: setting up and implement-
ing general rules and regulations for migrants,
refugees, travel, antibiotic misuse, food market
and network; in addition, all these changing con-
ditions require the development of a vast early
global warming system, akin to the high perfor-
mance computer networks — the grids — set up
by physicists and mathematicians
• Public health practices have to be rapidly and
dramatically improved and collective action at
the population level is rapidly required. In partic-
ular, the problem of water access should be put
on national and international agendas and prior-
itized within the next few years, if we want to
avoid a major political crisis or a mere economic
solution to the problem
• Control of the human and non-human usage of an-
tiinfectives will become a necessity, and it is high
time to reinforce the established rules and regu-
lations, if we do not want the era of antibiotics
to come to a rapid end.
Such approaches are highly complex if consid-
ered in their globality — they need to be rede-
ﬁned in terms of either accessible or affordable
subprojects. They also entail, as mentioned before,
the use or development of new, powerful scientiﬁc
tools. So far, we have relied mostly on conventional
methods, logistics and tools, but new domains in
science are developing rapidly which we may take
advantage of. The previously mentioned challenges
can be approached in a more visionary way with
new scientiﬁc tools, which have evolved into new
opportunities. All these new domains of science and
technology are not speciﬁc to infectious diseases,
but are used extensively in many other ﬁelds of sci-
ence, engineering, economics, and are reciprocally
fuelled by these domains. They represent a unique
chance to solve some of the most important prob-
lems of mankind.
In summary, the juxtaposition of old challenges
and new opportunities in the infectious disease
world of the 21st century unveils major, potentially
dramatic problems, and simultaneously suggests
new approaches based on new domains of science
and technology to solve or mitigate them. It is an
exciting time, since old challenges can be met by
new opportunities. This will only be possible if sci-
entists themselves become socially cognizant and
ready to make society’s needs a priority of their
research. Nowotny and Gibbons29 have described
this commitment of scientists as ‘socially robust
science’. This clear commitment to societal needs
is a necessary condition if we want to provide
decent living conditions for the next generations.
In addition, the social responsibility of science
has also to deﬁne how the individual’s rights are
to be respected. The events of September 2001,
the many wars worldwide, the threat of bioterror-
ism, all lead to stronger policing systems, instead of
democratic governments: the security of the world
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has certainly to be enhanced, but not at the price
of reducing the individual’s.
Finally, besides modern science and technology
organized into a socially robust system to meet the
challenges of the 21st century, two important issues
have to be dealt with urgently. Education, particu-
larly of women, and human rights — as fought for
by the late Jonathan Mann — are indispensable for
the development of a better world, in which the
challenges of infectious diseases and health are bal-
anced by equal opportunities for all.
Conﬂict of interest: No conﬂicting interest de-
clared.
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